180 related articles for article (PubMed ID: 34918657)
21. Correlation between X-ray cross-complementing group 1 polymorphisms and the onset risk of glioma: A meta-analysis.
Gu X; Sun H; Chang L; Sun R; Yang H; Zhang X; Cong X
Neural Regen Res; 2013 Sep; 8(26):2468-77. PubMed ID: 25206557
[TBL] [Abstract][Full Text] [Related]
22. Association between DNA repair genes (XPD and XRCC1) polymorphisms and susceptibility to age-related cataract (ARC): a meta-analysis.
Zheng LR; Ma JJ; Zhou DX; An LF; Zhang YQ
Graefes Arch Clin Exp Ophthalmol; 2014 Aug; 252(8):1259-66. PubMed ID: 24906341
[TBL] [Abstract][Full Text] [Related]
23. Association between X-Ray Repair Cross-Complementing Group 1 Arg399Gln Polymorphism and Cervical Cancer Risk: A Meta-Analysis in the Chinese Population.
Zhang F; Li B; Wu HY; Shang LX
Gynecol Obstet Invest; 2017; 82(4):382-387. PubMed ID: 27487002
[TBL] [Abstract][Full Text] [Related]
24. Association between X-ray repair cross-complementing group 1(XRCC1) Arg399Gln polymorphism and endometriosis: A systematic review and meta-analysis.
Lv MQ; Wang J; Yu XQ; Hong HH; Ren WJ; Ge P; Zhou DX
Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():12-20. PubMed ID: 28926725
[TBL] [Abstract][Full Text] [Related]
25. DNA repair gene XRCC1 polymorphisms and head and neck cancer risk: an updated meta-analysis including 16344 subjects.
Lou Y; Peng WJ; Cao DS; Xie J; Li HH; Jiang ZX
PLoS One; 2013; 8(9):e74059. PubMed ID: 24086310
[TBL] [Abstract][Full Text] [Related]
26. X-ray repair cross-complementing group 1 Arg399Gln gene polymorphism and susceptibility to colorectal cancer:a meta-analysis.
Zeng FR; Ling Y; Yang J; Tian XC; Yang X; Luo RC
Tumour Biol; 2013 Feb; 34(1):555-63. PubMed ID: 23188703
[TBL] [Abstract][Full Text] [Related]
27. Genetic polymorphisms of XRCC1 and leukemia risk: a meta-analysis of 19 case-control studies.
Zhang H; Liu H; Jiang G
PLoS One; 2013; 8(11):e80687. PubMed ID: 24363792
[TBL] [Abstract][Full Text] [Related]
28. Associations between three XRCC1 polymorphisms and glioma risk: a meta-analysis.
Zhang H; Liu H; Knauss JL
Tumour Biol; 2013 Oct; 34(5):3003-13. PubMed ID: 23712607
[TBL] [Abstract][Full Text] [Related]
29. Associations between XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms and risk of differentiated thyroid carcinoma: a meta-analysis.
Du Y; Han LY; Li DD; Liu H; Gao YH; Sun DJ
Asian Pac J Cancer Prev; 2013; 14(9):5483-7. PubMed ID: 24175846
[TBL] [Abstract][Full Text] [Related]
30. The Association Between the XRCC1 Arg399Gln Polymorphism and the Risk of Head and Neck Cancer: An Updated Meta-Analysis Including 14586 Subjects.
Xia S; Wu S; Wang M
Technol Cancer Res Treat; 2021; 20():15330338211033060. PubMed ID: 34278875
[TBL] [Abstract][Full Text] [Related]
31. A Meta-Analysis for Association of XRCC1, XRCC2 and XRCC3 Polymorphisms with Susceptibility to Thyroid Cancer.
Mandegari M; Dastgheib SA; Asadian F; Shaker SH; Tabatabaie SM; Kargar S; Sadeghizadeh-Yazdi J; Neamatzadeh H
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2221-2236. PubMed ID: 34319046
[TBL] [Abstract][Full Text] [Related]
32. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and risk of childhood acute lymphoblastic leukemia: a meta-analysis.
Wang L; Yin F; Xu X; Hu X; Zhao D
PLoS One; 2012; 7(4):e34897. PubMed ID: 22529951
[TBL] [Abstract][Full Text] [Related]
33. Association between Polymorphisms of X-Ray Repair Cross Complementing Group 1 Gene and Pancreatic Cancer Risk: a Systematic Review with Meta-Analysis.
Chen J; Wang H; Li Z
Pathol Oncol Res; 2019 Jul; 25(3):897-904. PubMed ID: 29285737
[TBL] [Abstract][Full Text] [Related]
34. XRCC1 gene polymorphisms and glioma risk in Chinese population: a meta-analysis.
He LW; Shi R; Jiang L; Zeng Y; Ma WL; Zhou JY
PLoS One; 2014; 9(11):e111981. PubMed ID: 25375625
[TBL] [Abstract][Full Text] [Related]
35. The XRCC1 Arg194Trp and Arg280His polymorphisms in head and neck cancer susceptibility: a meta-analysis.
Zhou X; Gu L; Zeng Y; Wei L; Ying M; Wang N; Su C; Wang Y; Liu C
Tumour Biol; 2014 Nov; 35(11):10665-76. PubMed ID: 25062722
[TBL] [Abstract][Full Text] [Related]
36. XRCC1 Arg194Trp and Arg399Gln polymorphisms are significantly associated with shorter survival in acute myeloid leukemia.
Bănescu C; Duicu C; Trifa AP; Dobreanu M
Leuk Lymphoma; 2014 Feb; 55(2):365-70. PubMed ID: 23662987
[TBL] [Abstract][Full Text] [Related]
37. XRCC1 polymorphisms are associated with cervical cancer risk and response to chemotherapy: a systematic review and meta-analysis.
Shuai HL; Luo X; Yan RL; Li J; Chen DL
Asian Pac J Cancer Prev; 2012; 13(12):6423-7. PubMed ID: 23464469
[TBL] [Abstract][Full Text] [Related]
38. The XRCC1 Arg194Trp polymorphism was associated with the risk of head and neck squamous cell carcinoma development: Results from a systematic review and meta-analysis.
Mohtasham N; Najafi-Ghobadi K; Abbaszadeh H
Cancer Rep (Hoboken); 2023 Mar; 6(3):e1776. PubMed ID: 36573562
[TBL] [Abstract][Full Text] [Related]
39. Association between XRCC1 polymorphisms and laryngeal cancer susceptibility in a Chinese sample population.
Wu WQ; Zhang LS; Liao SP; Lin XL; Zeng J; Du D
Genet Mol Res; 2016 Oct; 15(4):. PubMed ID: 27808358
[TBL] [Abstract][Full Text] [Related]
40. Association between polymorphisms in XRCC1 gene and clinical outcomes of patients with lung cancer: a meta-analysis.
Cui Z; Yin Z; Li X; Wu W; Guan P; Zhou B
BMC Cancer; 2012 Feb; 12():71. PubMed ID: 22339849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
